Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Wardlaw

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Pulmonary DisordersKerry Woolnough, Andrew J Wardlaw
Experimental Dermatology|May 29, 2008
A new paradigm of eosinophil granulocytes: neuroimmune interactionsUlrike Raap, Andrew J Wardlaw
Mycopathologia|May 27, 2021
Allergic fungal airways disease (AFAD): an under-recognised asthma endotypeCatherine H Pashley, Andrew J Wardlaw
Seminars in Respiratory and Critical Care Medicine|April 14, 2006
Eosinophilic airway disordersKaren A Scott, Andrew J Wardlaw
Seminars in Respiratory and Critical Care Medicine|October 11, 2012
Advances in the management of severe asthmaSalman Siddiqui, Sherif Gonem, Andrew J Wardlaw
Clinical Allergy and Immunology|October 2, 2001
EosinophilsDouglas S Robinson, A Barry Kay, Andrew J Wardlaw
Experimental Lung Research|May 6, 2009
The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cellsCaroline Day, Rashmika Patel, Cristina Guillen, et al.
Clinical Medicine (London, England)|May 7, 2002
Duplicate publicationIan D Pavord, Michael D L Morgan, Andrew J Wardlaw
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 11, 2017
rAsp f3 and rAsp f4 are associated with bronchiectasis in allergic fungal airways diseaseKerry Woolnough, Michelle Craner, Catherine H Pashley, et al.
Current Opinion in Pulmonary Medicine|November 22, 2014
Allergic fungal airway disease: pathophysiologic and diagnostic considerationsKerry Woolnough, Abbie Fairs, Catherine H Pashley, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Pulmonary DisordersKerry Woolnough, Andrew J Wardlaw
Experimental Dermatology|May 29, 2008
A new paradigm of eosinophil granulocytes: neuroimmune interactionsUlrike Raap, Andrew J Wardlaw
Mycopathologia|May 27, 2021
Allergic fungal airways disease (AFAD): an under-recognised asthma endotypeCatherine H Pashley, Andrew J Wardlaw
Seminars in Respiratory and Critical Care Medicine|April 14, 2006
Eosinophilic airway disordersKaren A Scott, Andrew J Wardlaw
Seminars in Respiratory and Critical Care Medicine|October 11, 2012
Advances in the management of severe asthmaSalman Siddiqui, Sherif Gonem, Andrew J Wardlaw
Clinical Allergy and Immunology|October 2, 2001
EosinophilsDouglas S Robinson, A Barry Kay, Andrew J Wardlaw
Experimental Lung Research|May 6, 2009
The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cellsCaroline Day, Rashmika Patel, Cristina Guillen, et al.
Clinical Medicine (London, England)|May 7, 2002
Duplicate publicationIan D Pavord, Michael D L Morgan, Andrew J Wardlaw
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 11, 2017
rAsp f3 and rAsp f4 are associated with bronchiectasis in allergic fungal airways diseaseKerry Woolnough, Michelle Craner, Catherine H Pashley, et al.
Current Opinion in Pulmonary Medicine|November 22, 2014
Allergic fungal airway disease: pathophysiologic and diagnostic considerationsKerry Woolnough, Abbie Fairs, Catherine H Pashley, et al.
Pageof 8